CSF2–STAT5 Signaling in TAMs Contributes to CSF1R Inhibition Resistance

Article navigation

Research Watch| January 12 2022

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2021

American Association for Cancer Research.

Cancer Discov (2022) 12 (1): OF2.

Abstract

CSF1R inhibition combined with STAT5 blockade normalized TAM phenotype and sustained tumor control.

2021

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.